<a href='https://email.asam.org/t/t-i-wljtriy-l-t/'>Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations</a>
Substance Use and Addiction Journal
This is a narrative review of methadone and buprenorphine regulations, prescriber eligibility, dispensing models, and coverage across eight countries: the United States, Canada, the United Kingdom, Russia, France, Iran, Australia, and Portugal. The study identified several key barriers to MOUD: requirements for daily supervised dosing, restricted community prescribing, and stigmatizing drug scheduling. The authors highlight policies that improved MOUD access without compromising safety such as: 1) community pharmacy dispensing supports in the U.K. and Australia, 2) liberal buprenorphine prescribing in primary care in France, and 3) decriminalization and expansion of low-threshold public health models in Portugal and Iran.
 
<a href='https://email.asam.org/t/t-e-wljtriy-l-jt/'>Read this issue of the ASAM Weekly</a>
<a href='https://email.asam.org/t/ViewEmail/t/409ED172E9728DA22540EF23F30FEDED?alternativeLink=True'>Subscribe to the ASAM Weekly</a>
<a href='https://email.asam.org/t/ViewEmail/t/7B8FCC540811FB9A2540EF23F30FEDED/C67FD2F38AC4859C/?tx=0&previewAll=1&print=1&source=PrintPreview&context=BE1559E32AC7F640D744A813E2B67A32'>Visit ASAM</a>

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Lead: Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations

This Week in Addiction Medicine from ASAM

AI Chapters

AI Insights

Reviews